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Body mass indexPolymorphisms of butyrylcholinesterase (BChE) have been reported to be associated toweight, BMI variance and
hypertriglyceridemia in adults and adolescents. The aim of the present studywas to investigate the association of
−116A (SNP: G/A; rs1126680) and 1914G (SNP: A/G; rs3495) variants of BCHE gene with anthropometric and
biochemical variables associated with obesity in population sample of 115 individuals, from Southern Brazil.
Participants were grouped in two categories: obese (BMI ≥ 30) and non-obese (BMI b 30). The 1914G allele
showed signiﬁcantly higher frequency in the obese group, and carriers of 1914G allele showed lower mean
BChE activity when compared to 1914A carriers (p = 0.006). Higher means of BMI (p = 0.02) and triglyceride
(TG; p = 0.01) were found in 1914G carriers (BMI = 27.57kg/m2; TG = 150.8 mg/dL) when compared to
1914A homozygotes (BMI = 25.55 kg/m2; TG = 107.9 mg/dL). Carriers of the −116A allele showed lower
mean BChE activity than usual homozygotes, and the−116A variant was found in cis with 1914G (p b 0.0001;
D′ = 1). The region of BCHE gene that contains the 1914Gmutation site is target of microRNAs (miRs) and the
response of BChE to glucocorticoids is especially inﬂuenced by these miRs. Therefore, it is possible that the
1914G allele can be interfering in gluconeogenesis, hyperglycemia, lipolysis and body fat distribution. This
lower activity may cause an imbalance in lipid metabolism, which may lead to an increased predisposition to
obesity and to a lower ability to maintain metabolic homeostasis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Butyrylcholinesterase (BChE; EC 3.1.1.8) is a serine hydrolase which
is related to lipid metabolism and has been associated to metabolic
syndrome risk variables, such as body mass index (BMI), waist–hip
ratio, waist circumference, weight, cholesterol and triglyceride levels
(Alcantara et al., 2005; Benyamin et al., 2011; Furtado-Alle et al., 2008;
Iwasaki et al., 2007; Randell et al., 2005; Souza et al., 2005).
The non-coding exon 1 of the BCHE gene (3q26.1–q26.2) contains an
SNP at −116 site (SNP: G/A; rs1126680), being the −116A allele ﬁrst
identiﬁed with a frequency of 8% (Bartels et al., 1990) and associated
with a lower enzyme activity (Furtado-Alle et al., 2008) and to hypertri-
glyceridemia in obese adolescents (Chaves et al., 2013). The second
BCHE polymorphism investigated in this study is located at exon 4,
also in a non-coding region (3′UTR, 189 bases after the stop codon) atutyrylcholinesterase; BMI, body
s; HDL-cholesterol, high-density
sterol, low-density lipoprotein;
ngle nucleotide polymorphism.
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ights reserved.1914 site (SNP: A/G; rs3495). The 1914G allele was originally described
with a frequency of 26%, and found in cis with the−116A allele (Bartels
et al., 1990).
This study measured the enzymatic activity of BChE in a sample of
115 adults from Curitiba, Brazil, correlating it with the SNPs −116A
and 1914G of BCHE gene, and also verifying their inﬂuence on anthropo-
metric and biochemical variables associated with obesity.
2. Materials and methods
2.1. Samples
The sample consisted of 115 individuals from Southern Brazil
(all Euro-Brazilian, 35% men and 65% women), 27 of which are
obese (BMI ≥ 30 kg/m2) and 88 non-obese (BMI b 30 kg/m2). Weight
and height were measured with accuracy of 0.1 kg and 0.1 cm, respec-
tively. The study was approved by the Ethics Committee of the Federal
University of Paraná.
2.2. DNA and plasma analysis
DNA was extracted from peripheral blood samples by a salting-out
method (Lahiri and Nurnberger, 1991) and then diluted to a ﬁnal
Table 2
Mean (±standard error) BChE activity (KU/L) and BMI (kg/m2) and comparisons between
mutant allele carriers and homozygotes for the usual alleles for −116 and 1914 sites of
BCHE gene.
1914 AG + 1914 GG
(N = 87)
1914 AA
(N = 28)
t (p)
BChE activity 4.21 ± 1.20 5.06 ± 1.71 t = 2.80 (p = 0.006)⁎
BMI 27.57 ± 4.86 25.55 ± 3.37 t = 2.34 (p = 0.02)⁎
−116 AG + −116 AA
(N = 15)
−116 GG
(N = 100)
BChE activity 3.59 ± 1.31 4.54 ± 1.14 t = 2.59 (p = 0.01)⁎
BMI 27.61 ± 4.32 26.85 ± 4.74 t = −0.58 (p = 0.56)
⁎ Signiﬁcant values.
AA AG GG 
Enzyme Activity 
Triglyceride Concentration
(a)
(b)
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and 4 (rs1126680 and rs3495 respectively) was obtained by TaqMan
SNP Genotyping Assay (Applied Biosystems). The reactions were per-
formed in a Mastercycler realplex 2 according to the following steps:
(1) 50 °C/2 min, (2) 95 °C/10 min, (3) repeat 50 times 95 °C/15 s, in-
terspersed by 62 °C/min. Three previously sequenced control samples,
representative of each of the possible genotypes (usual homozygote,
heterozygote andmutant homozygote)were included in every reaction
for both SNPs.
The plasma BChE activity was measured using propionylthiocholine
as substrate at 25 °C (Dietz et al., 1972). Glucose, triglycerides, total
cholesterol, LDL-cholesterol and HDL-cholesterol were measured by
standard automated methods.
2.3. Statistical analysis
Frequency distributions, mean ± S.E., variances and t-test were cal-
culated using Statistica forWindows (StatSoft Inc. 1996, Version 5.0).χ2
tests were performed using Clump (Sham and Curtis, 1995). Multiple
regression analysis was performed by using SPSS for Windows (SPSS
Inc. released 2004, Version 13.0, Chicago).
3. Results
The genotype distributions are in Hardy–Weinberg equilibrium in
both sites (−116 and 1914). Table 1 summarizes the results of allele
frequency of the studied variants in the total sample, and in obese and
non-obese. The −116A allele was found with a similar frequency be-
tween obese and non-obese (χ2 = 0.02, p = 0.87). The 1914G allele
was found with different frequencies between obese and non-obese
(χ2 = 5.21, p = 0.02). Since the frequency of the 1914G allele was sig-
niﬁcantly higher in the obese group, a multiple regression analysis was
conducted, considering sex, age, and variants of the sites −116 and
1914 as independent variables and obesity as the dependent variable.
This result conﬁrmed that the 1914G allele acts as an independent factor
in the increase of BMI (β = −1.99 ± 0.76, p = 0.01). The age factor
was also signiﬁcant (β = 0.18 ± 0.06, p = 0.003), in agreement with
what has been described in the literature, the BMI increases on average
with advancing age (Rodgers, 2002; Walsh et al., 2011).
Table 2 shows comparisons between the genotypes of the −116A
and 1914G variants, mean BChE activity and BMI. The activity was sig-
niﬁcantly lower in −116A allele carriers than in usual homozygotes.
The activity was also signiﬁcantly lower in carriers of 1914G allele
when compared to usual homozygotes. Higher mean BMI was found
in individual 1914G homozygote when compared to 1914A homozy-
gotes. Therewas no signiﬁcant difference inmeanBMIwhen comparing
usual homozygotes and carriers of−116A allele.
Fig. 1 shows histograms of the BChE activities and the triglyceride
levels (mg/dL) in samples grouped according to the genotype of the
1914 site.
Considering that linkage disequilibrium analysis conﬁrmed that the
variant −116A is in cis with 1914G (χ2 = 17.25, p b 0.0001, D′ = 1),
the biochemical variables (total cholesterol, LDL and HDL-cholesterol,
triglycerides and glycemia) were analyzed considering both sites,
by comparing carriers of both variants and usual homozygotes forTable 1
Allele frequencies of−116A and 1914G SNPs (% ± standard error) in the total sample, in
obese and in non-obese individuals.
Total (n = 115) Obese (n = 27) Non-obese (n = 88)
−116 A = 6.96 ± 1.67 A = 5.56 ± 3.12 A = 7.83 ± 2.94
G = 93.04 ± 1.67 G = 94.44 ± 3.12 G = 92.17 ± 2.94
1914 A = 40.09 ± 3.29 A = 25.93 ± 5.96 A = 44.64 ± 3.83
G = 59.91 ± 3.29 G = 74.07 ± 5.96 G = 55.36 ± 3.83both sites. This analysis showed signiﬁcant differences only in tri-
glyceride levels: higher levels were found in carriers of both variants
(150.8 mg/dL) when compared with homozygotes for −116G and
1914A alleles (107.9 mg/dL; t = −2.58, p = 0.01).
4. Discussion
Although the role of BChE in metabolic pathways is not fully elu-
cidated, it has been proposed that it could be responsible for theAAAGGG
Fig. 1. a) Enzyme activity (KU/L) of BChE and b) triglyceride concentration (mg/dL) in
sample categorized according to the genotype of SNP 1914 do gene BCHE.
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metabolism and liver lipogenesis (Chu et al., 1978; Clitherow et al.,
1963; Kutty et al., 1981; Siskova et al., 2012). In obese individuals,
there is a tendency of the BChE activity to be higher than in non-
obese, which may be related to the increased availability of free
fatty acids characteristic of obesity (Alcantara et al., 2005; Furtado-
Alle et al., 2008; Randell et al., 2005). Additionally, association of
BCHE gene variants, including −116A variant, with obesity and lipid
and biochemical proﬁles have been reported (Benyamin et al., 2011;
Furtado-Alle et al., 2008; Scacchi et al., 2011).
Acetylcholine is the main neurotransmitter of the vagus nerve
(Borovikova et al., 2000; Wang et al., 2003, 2004). According to Tracey
(2007), obesity may be characterized by a decrease of efferent neural,
and high levels of cytokines, resulting in metabolic disorders mediated
by chronic inﬂammation. Cytokine-producing cells, among them mac-
rophages, express acetylcholine receptors which transduce an intracel-
lular signal inhibiting cytokine synthesis (Wang et al., 2003, 2004).
BChE may play an indirect role in the cytokine production, and thus in
the inﬂammatory conditions and their consequences, which are charac-
teristic of obesity and metabolic syndrome. The increased BChE activity
may lead to a greater degradation of acetylcholine and consequently to
its lower inhibitory effect on the production of cytokines. According to
the work of Silva et al. (2012) a program of 12 weeks of physical exer-
cise was effective in decreasing BChE activity in obese adolescents, in
addition to the signiﬁcant improvement in lipid proﬁle. Thus, the in-
creased BChE activity in obese individuals, reported in several papers,
may be a consequence of metabolic imbalance caused by obesity, and
its activity can be reduced with the improvement of metabolic and
physiological conditions related to physical exercise.
The 1914G allele may be related to decreased enzyme activity, even
in subjectswith higher BMI. As described in ourwork, the1914G allele is
more frequent in obese individuals, and the lower activity of BChE in
these individuals may be conferring a beneﬁcial effect, which indirectly
decreases production of inﬂammatory cytokines.
The lower mean BChE activity in carriers of allele −116A was also
found in this study sample which agrees with the results of previous
studies (Chaves et al., 2013). It is noteworthy that our study is the ﬁrst
to consider the 1914Gmutation in this context, and our ﬁndings suggest
that the 1914G variant is associated to higher BMI and triglyceride levels
and to lower BChE activity. Knowing that the −116A is less frequent
than 1914G (Table 1), and that both alleles are found in cis, due to
their linkage disequilibrium, it is possible that the lower BChE activity,
attributed originally to the−116A allele, is caused by 1914G allele con-
comitant presence.
It was reported that 3′UTR region of BChE is target of at least 116
microRNAs (miRs) that may act as silencers of mRNA BChE (Hanin
and Soreq, 2011). This region contains the site of the 1914G variant
which may interfere in the binding of hsa-miR-498 and hsa-miR-662,
and therefore change the levels of enzyme produced. In the same
study (Hanin and Soreq, 2011) it was found that the response of BChE
to glucocorticoids is especially inﬂuenced by these miRs. Knowing that
the glucocorticoids have an effect on gluconeogenesis, hyperglycemia,
lipolysis and body fat distribution (Peckett et al., 2011), BChE can be in-
terfering in thesemetabolic pathways, especially when the 1914G allele
decreases BChE activity. This lower activity may cause an imbalance
in lipid metabolism, which may lead to an increased predisposition to
obesity and to a lower ability to maintain the metabolic homeostasis.
The K variant (SNP: G/A; rs1803274; p.A539T; 1615 nt) of the BCHE
gene is the most common variant of the coding region and has been
associated with higher BMI variance. It was shown that, although the
K variant was originally associated to lower BChE activity, it is not asso-
ciated with decreased BChE activity by itself, being the −116A variant
necessary for this decrease (Furtado-Alle et al., 2008). Podoly et al.
(2009) suggest that a structural change, determined by the substitutionA539T at the C-terminal region, important in BChE tetramerization,
leads to a reduction in its hydrolytic activity due to instability caused
by such replacement. Considering that the alleles−116A, K and 1914G
are preferentially found in cis and the lack of studies with the 1914G
variant, it is possible that this variant is essential to regulate BChE activ-
ity and obesity-related variables. Although we cannot rule out linkage
disequilibrium between 1914G allele and a regulatory site, facing our
results, we suggest that the 1914G allele has a fundamental inﬂuence
in BChE activity levels, and consequently in the metabolic processes it
participates.
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